Share this post on:

Product Name :
L-869298

Search keywords :
L-869298

drugId :
null

Target Vo:
Fibroblast growth factor receptor 4

Target Vo Short Name :
FGFR4

Moa_Name:
Fibroblast growth factor receptor 4 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Merck Frosst Company

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Arthritis, Rheumatoid

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Aurora B Antibody
ATP citrate lyase Antibody
Phospho-HSF1 (Ser326) Antibody(YA894): Phospho-HSF1 (Ser326) Antibody(YA894) is an unconjugated, approximately 57 kDa, rabbit-derived, anti-HSF1 (Ser326)(YA894) monoclonal antibody. Phospho-HSF1 (Ser326) Antibody(YA894) can be used for: WB, IF-Cell, IHC-P, IP, FC expriments in human background without labeling.

Share this post on:

Author: Interleukin Related